<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=mylan+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss"><channel><title>mylan pharma - BingNews</title><link>http://www.bing.com/news/search?q=mylan+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>mylan pharma</title><link>http://www.bing.com/news/search?q=mylan+pharma&amp;setmkt=en-US&amp;FORM=BNFD&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3546236a2c444ebf718f2e23b449c8&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fmylan-sues-generic-rival-teva-for-blocking-copycats-its-branded-multiple-sclerosis-med&amp;c=5847595597397724905&amp;mkt=en-us</link><description>Teva Pharmaceutical is facing down plenty of lawsuits. Now, one of its chief rivals in the generics field is adding another case to Teva's plate. Mylan, which has merged with Pfizer's Upjohn to form ...</description><pubDate>Thu, 01 Jul 2021 03:12:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Former Mylan executive pleads guilty to insider trading that netted him $4.27M</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3546236a2c444ebf718f2e23b449c8&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2fformer-mylan-executive-pleads-guilty-to-insider-trading-netted-him-4-27m&amp;c=8851068823152877188&amp;mkt=en-us</link><description>A former Mylan executive has pleaded guilty to an insider trading scheme that netted him $4.27 million. After leaving the company in 2017, Dayakar Mallu received information on earnings reports, FDA ...</description><pubDate>Mon, 20 Sep 2021 03:10:00 GMT</pubDate><News:Source>FiercePharma</News:Source></item><item><title>Mylan sues Teva, alleging Teva stifled competition for its MS drug Copaxone</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3546236a2c444ebf718f2e23b449c8&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2fmylan-sues-teva-alleging-teva-023200971.html&amp;c=7308404541266982196&amp;mkt=en-us</link><description>Jul. 4—MORGANTOWN — The tangled world of generic pharmaceuticals took another twist last week, as Mylan Pharmaceuticals filed suit in federal court against Israel-based Teva, alleging Teva illegally ...</description><pubDate>Sun, 04 Jul 2021 17:01:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>Pharma company tentatively agrees to $335M opioid settlement</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3546236a2c444ebf718f2e23b449c8&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2fpharma-company-tentatively-agrees-335m-192801746.html&amp;c=5945468677403624680&amp;mkt=en-us</link><description>A pharmaceutical company has agreed in principle to pay hundreds of millions of dollars which officials say will help combat the opioid crisis across the nation. Under the tentative settlement, Mylan ...</description><pubDate>Mon, 07 Apr 2025 12:28:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>Pharmaceutical firm Mylan will pay up to $335M over opioid drug crisis</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=6a3546236a2c444ebf718f2e23b449c8&amp;url=https%3a%2f%2fbrooklyneagle.com%2f306441%2fpharmaceutical-firm-mylan-will-pay-up-to-335m-over-opioid-drug-crisis%2f&amp;c=818844093169062369&amp;mkt=en-us</link><description>STATEWIDE — New York Attorney General Letitia James’ office has helped to secure a multistate settlement in principle with the successor company of pharmaceutical manufacturer Mylan Inc. that will ...</description><pubDate>Sun, 06 Apr 2025 17:01:00 GMT</pubDate><News:Source>Brooklyn Daily Eagle</News:Source></item></channel></rss>